As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth at 4.90% CAGR. Increasing development of radioisotopes to curb the cases of cancer have propelled the
Radiopharmaceuticals Market to be US$ 6.2 Billion by 2022 | Future Market Insights